Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk factor analysis in differentiated thyroid cancer.

B Cady, C E Sedgwick, W A Meissner

    Cancer
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Radiation effects of the atomic bomb among the natives of Nagasaki, Kyushu.

    American journal of clinical pathology·2010
    Same author

    The distribution of parietal cells in gastric disease.

    The American journal of pathology·2010
    Same author

    Atomic bomb surface burns; some clinical observations among prisoners of war rescued at Nagasaki, Kyushu.

    The Journal of the Indiana State Medical Association·2010
    Same author

    Distribution of parietal cells in gastric disease.

    Archives of pathology·2010
    Same author

    Mucormycosis of the Central Nervous System Associated with Hemochromatosis: Report of a Case.

    The American journal of pathology·2009
    Same author

    Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.

    Annals of surgical oncology·2008
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    See all related articles

    Differentiated thyroid carcinoma risk stratification by age and sex significantly impacts recurrence and death rates. Younger patients (men ≤40, women ≤50) have better outcomes than older patients, guiding personalized treatment strategies.

    Area of Science:

    • Endocrinology
    • Oncology
    • Epidemiology

    Background:

    • Differentiated thyroid carcinoma (DTC) prognosis varies significantly among patients.
    • Identifying reliable prognostic factors is crucial for effective patient management and treatment stratification.

    Purpose of the Study:

    • To evaluate the long-term impact of age and sex-based risk stratification on recurrence and mortality in differentiated thyroid carcinoma.
    • To determine if basic risk group definitions are more influential than other clinicopathological factors.

    Main Methods:

    • Longitudinal follow-up study of 600 patients with primary differentiated thyroid carcinoma.
    • Minimum follow-up duration of 15 years, maximum of 45 years.
    • Risk groups defined by age (men ≤40, women ≤50 for low-risk) and sex.

    Related Experiment Videos

    Main Results:

    • Significantly lower recurrence (11% vs. 33%) and death (4% vs. 27%) rates in low-risk versus high-risk groups.
    • Age and sex stratification proved more impactful than pathologic type, disease extent, or treatment.
    • Radioactive iodine efficacy differed markedly: 70% cure in low-risk metastatic disease vs. 10% in high-risk.

    Conclusions:

    • Age and sex are powerful independent predictors of differentiated thyroid carcinoma outcomes.
    • Estrogen's potential role in modulating thyroid cancer progression warrants further investigation.
    • Estrogen-based therapies may be beneficial for progressive metastatic differentiated thyroid cancer.